 Codexis NASDAQ:CDXS was downgraded by Zacks Investment Research from a hold rating to a sell rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial ... 